Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Discovery Leads to Simple Blood or Urine Test to Identify Blinding Disease

Published: Monday, October 21, 2013
Last Updated: Monday, October 21, 2013
Bookmark and Share
Breakthrough discovery in diagnosing retinitis pigmentosa, a blinding disease that affects about 1 in 4,000 people in the United States.

Rong Wen, M.D., Ph.D., and Byron Lam, M.D., professors of ophthalmology at Bascom Palmer, in collaboration with biochemist Ziqiang Guan, Ph.D., a research associate professor at Duke University Medical School, discovered a key marker in blood and urine that can identify people who carry genetic mutations in a gene responsible for retinitis pigmentosa (RP). “A simple urine test can tell who has the RP-causing mutations,” said Dr. Wen. “Collecting urine is non-invasive and easy, especially from young children.”

The first mutation in this gene, named DHDDS, was identified in 2011 by scientists at the Miller School of Medicine, including Stephan Züchner, M.D., Ph.D., professor and Interim Chair of the Dr. John T. Macdonald Foundation Department of Human Genetics, Wen, Lam, and Margaret A. Pericak-Vance, Ph.D., Director of the John P. Hussman Institute for Human Genomics, on behalf of a South Florida couple who were searching for the reason why three of their children were blinded by RP. Mutations in this gene are more common in people of Ashkenazi Jewish heritage than in the general population. RP is a group of inherited eye diseases that cause progressive vision loss and blindness due to degeneration of the retina, the layer of light-sensitive tissue at the back of the eye.

“It is our vision that every patient who is affected with an inherited eye disease like RP should have access to a clinician who is knowledgeable about the diseases, as well as to affordable diagnostic testing and counseling,” said Lam, director of Bascom Palmer’s hereditary eye disease center. “This diagnostic test is a powerful tool that will help in developing treatments for RP caused by DHDDS mutations.”

The DHDDS mutation has special meaning to the Lidsky family of South Florida. Three of the four Lidsky children, who are now in their 30s, began to lose their sight in their teens. “The fact that a simple blood or urine test can identify the genetic defect that causes this form of RP is very important,” said Betti Lidsky, mother of the children, and a founder of Hope for Vision, a non-profit organization dedicated to promoting retinal research. “I have tremendous hope in the doctors and scientists doing this life-changing work and am confident that RP is one step closer to being treated.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Diagnosing Bacterial Infections in Blood Samples
Researchers have diagnosed a bacterial infection from a blood sample in infants.
Neurodvelopmental Disorder Cause Linked to SON Gene
A genetic link has been discovered for a previously unxplained neurodevelopmental disorder.
World's Most In-Depth Study to Detect Alzheimer's Disease
A multisite team will see the most thorough and vigorous testing for Alzheimer's ever performed on volunteers.
Personalised Medicine: Dose by Design
Personalised medicine holds the promise of a new approach to healthcare, tailored exactly to our individual needs, as Congenica's Nick Lench discussed on a recent BBC Radio 4 programme.
Misdiagnosis in HCM Tests
Genetic tests for potentially fatal heart anomaly can misdiagnose condition in black Americans.
Computers Better Predict Lung Cancer Type, Severity
Study shows automating the analysis of cancer tissue samples increases the accuracy of tumor classification and patient prognoses.
Examining New Hypotheses for Undiagnosed Patients
UnDx Consortium gathers in San Diego to create new paths to identifying currently undiagnosed illnesses.
Automating Genetic Analysis
Researchers are looking to have computers help perform genetic analysis when scientists study a patient's genome to diagnose a disease.
Understanding Tumor Evolution
Study provides insight into tumor evolution; may point to improved diagnosis and treatment.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!